Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.

Martins RG, Parvathaneni U, Bauman JE, Sharma AK, Raez LE, Papagikos MA, Yunus F, Kurland BF, Eaton KD, Liao JJ, Mendez E, Futran N, Wang DX, Chai X, Wallace SG, Austin M, Schmidt R, Hayes DN.

J Clin Oncol. 2013 Apr 10;31(11):1415-21. doi: 10.1200/JCO.2012.46.3299. Epub 2013 Mar 4.

PMID:
23460709
2.

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck.

Levy AR, Johnston KM, Sambrook J, Donato B, Penrod JR, Corral M, Chasen M.

Curr Med Res Opin. 2011 Dec;27(12):2253-9. doi: 10.1185/03007995.2011.633989. Epub 2011 Nov 14. Review.

PMID:
22017232
3.

Targeted therapy: A novel approach in head and neck cancer.

Christy AW, Bojan A.

Indian J Dent Res. 2013 Mar-Apr;24(2):261-6. doi: 10.4103/0970-9290.116692. Review.

4.

Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer.

Fujii M.

Int J Clin Oncol. 2014 Apr;19(2):220-9. doi: 10.1007/s10147-014-0671-9. Epub 2014 Feb 28. Review.

PMID:
24578179
5.

Definitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis.

Aguiar PN Jr, Tadokoro H, da Silva GF, Landgraf MM, Noia Barreto CM, Filardi BA, Lopes GL Jr, Oliveira P, de Mello RA.

Future Oncol. 2016 Dec;12(23):2755-2764. Epub 2016 Aug 23. Review.

PMID:
27549331
6.

Chemotherapy in locally advanced head and neck squamous cell carcinoma.

Gyawali B, Shimokata T, Honda K, Ando Y.

Cancer Treat Rev. 2016 Mar;44:10-6. doi: 10.1016/j.ctrv.2016.01.002. Epub 2016 Jan 22. Review.

PMID:
26924194
7.

Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model.

Strigari L, Pinnarò P, Carlini P, Torino F, Strolin S, Minosse S, Sanguineti G, Benassi M.

Crit Rev Oncol Hematol. 2016 Jun;102:101-10. doi: 10.1016/j.critrevonc.2016.04.004. Epub 2016 Apr 22. Review.

PMID:
27157527
8.

Cisplatin based chemoradiation late toxicities in head and neck squamous cell carcinoma patients.

Rivelli TG, Mak MP, Martins RE, da Costa e Silva VT, de Castro G Jr.

Discov Med. 2015 Jul-Aug;20(108):57-66. Review.

9.

Anti EGFR therapy in the treatment of non-metastatic head and neck squamous cell carcinoma: The current evidence.

Benson R, Mallick S, Julka PK, Rath GK.

J Egypt Natl Canc Inst. 2016 Sep;28(3):141-8. doi: 10.1016/j.jnci.2016.04.003. Epub 2016 May 6. Review.

10.
11.

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.

Ahn MJ, D'Cruz A, Vermorken JB, Chen JP, Chitapanarux I, Dang HQ, Guminski A, Kannarunimit D, Lin TY, Ng WT, Park KU, Chan AT.

Oral Oncol. 2016 Feb;53:10-6. doi: 10.1016/j.oraloncology.2015.11.019. Epub 2015 Dec 19. Review.

12.

Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications.

Perri F, Pacelli R, Della Vittoria Scarpati G, Cella L, Giuliano M, Caponigro F, Pepe S.

Head Neck. 2015 May;37(5):763-70. doi: 10.1002/hed.23837. Epub 2015 Jan 27. Review.

PMID:
24995469
13.
14.

Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.

Theunissen EA, Bosma SC, Zuur CL, Spijker R, van der Baan S, Dreschler WA, de Boer JP, Balm AJ, Rasch CR.

Head Neck. 2015 Feb;37(2):281-92. doi: 10.1002/hed.23551. Epub 2014 Jan 29. Review.

PMID:
24478269
15.

State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013.

Denaro N, Russi EG, Adamo V, Merlano MC.

Oncology. 2014;86(4):212-29. doi: 10.1159/000357712. Epub 2014 May 10. Review.

PMID:
24820548
16.

Molecular targeting agents in the context of primary chemoradiation strategies.

Laban S, Wang CJ, M√ľnscher A, Tribius S, Schafhausen P, Knecht R.

Head Neck. 2013 May;35(5):738-46. doi: 10.1002/hed.22012. Epub 2012 Jan 20. Review.

PMID:
22267285
17.

Head and neck cancer.

Argiris A, Karamouzis MV, Raben D, Ferris RL.

Lancet. 2008 May 17;371(9625):1695-709. doi: 10.1016/S0140-6736(08)60728-X. Review.

PMID:
18486742
18.

Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines.

Scheckenbach K, Wagenmann M, Freund M, Schipper J, Hanenberg H.

Klin Padiatr. 2012 Apr;224(3):132-8. doi: 10.1055/s-0032-1308989. Epub 2012 Apr 13. Review.

19.

Classifying squamous cell carcinoma of the head and neck: prognosis, prediction and implications for therapy.

Weiss J, Hayes DN.

Expert Rev Anticancer Ther. 2014 Feb;14(2):229-36. doi: 10.1586/14737140.2014.863154. Epub 2013 Dec 6. Review.

PMID:
24313652
20.

Molecular mechanisms of head and neck cancer.

Deshpande AM, Wong DT.

Expert Rev Anticancer Ther. 2008 May;8(5):799-809. doi: 10.1586/14737140.8.5.799. Review.

Supplemental Content

Support Center